Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03042702
Title A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Cellceutix Corporation
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.